|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ASHTON TECHNOLOGY GROUP INC, 10-Q, EX-10.6, 2000-11-14 |
Next: GENSTAR THERAPEUTICS CORP, S-3, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C> <C>
<PERIOD-TYPE> 3-MOS 6-MOS
<FISCAL-YEAR-END> MAR-31-2001 MAR-31-2001
<PERIOD-START> JUL-01-2000 APR-01-2000
<PERIOD-END> SEP-30-2000 SEP-30-2000
<CASH> 8,099,374 0
<SECURITIES> 9,954,400 0
<RECEIVABLES> 3,443,601 0
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 21,326,019 0
<PP&E> 3,153,182 0
<DEPRECIATION> 1,351,060 0
<TOTAL-ASSETS> 24,272,169 0
<CURRENT-LIABILITIES> 1,270,044 0
<BONDS> 0 0
0 0
6,567,000 0
<COMMON> 289,287 0
<OTHER-SE> 11,102,224 0
<TOTAL-LIABILITY-AND-EQUITY> 24,272,169 0
<SALES> 0 0
<TOTAL-REVENUES> 37,778 83,895
<CGS> 0 0
<TOTAL-COSTS> 0 0
<OTHER-EXPENSES> 4,158,422 7,506,073
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 863 7,985
<INCOME-PRETAX> (4,292,872) (7,407,034)
<INCOME-TAX> 0 0
<INCOME-CONTINUING> (4,292,872) (7,407,034)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (4,292,872) (7,407,034)
<EPS-BASIC> (0.16) (0.28)
<EPS-DILUTED> (0.16) (0.28)
</TABLE>
|
|